Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-25 @ 7:09 PM
Study NCT ID:
NCT01451632
Status:
COMPLETED
Last Update Posted:
2016-09-08
First Post:
2011-10-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Sponsor:
Merrimack Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-07
First Submit QC Date:
None
Study First Post Date:
2011-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-12
Results First Submit QC Date:
None
Results First Post Date:
2016-09-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-06
Last Update Post Date:
2016-09-08
Last Update Post Date Type:
ESTIMATED